Literature DB >> 32077338

Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Giacomo Montagna1, Monica Morrow1.   

Abstract

Introduction: The contralateral prophylactic mastectomy (CPM) rate in the U.S. has been steadily increasing. This is of particular concern because many women who undergo this procedure are candidates for breast-conserving surgery.Areas covered: CPM's medical benefit is related to the risk of contralateral cancer development and whether CPM provides a survival benefit. Contralateral cancer rates have decreased, and CPM does not provide a survival benefit. Other potential benefits of the procedure may be improved quality of life; these data are reviewed. Research efforts have been undertaken to better understand the decision-making process of patients who consider, and ultimately undergo, this procedure.Expert opinion: Decisional traits, personal values, the desire for peace of mind, and the desire to obtain breast symmetry are important factors that drive a woman's decision to undergo CPM. Additionally, many patients lack the knowledge on how different types of breast surgery impact outcomes. To improve the shared decision-making process, a stepwise approach to address possible misconceptions, and clarify the real risks/benefits of this procedure should be utilized. A clear recommendation (for/against) should be made for every patient with newly diagnosed breast cancer who considers CPM. Communication tools to assist patients and surgeons in this process are sorely needed.

Entities:  

Keywords:  Contralateral prophylactic mastectomy; benefits; harms; patient education; shared decision making

Mesh:

Year:  2020        PMID: 32077338      PMCID: PMC7193761          DOI: 10.1080/14737140.2020.1732213

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  86 in total

1.  Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.

Authors:  Laura Grimmer; Erik Liederbach; Jose Velasco; Catherine Pesce; Chi-Hsiung Wang; Katharine Yao
Journal:  J Am Coll Surg       Date:  2015-04-23       Impact factor: 6.113

2.  Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.

Authors:  Sarah T Hawley; Reshma Jagsi; Monica Morrow; Nancy K Janz; Ann Hamilton; John J Graff; Steven J Katz
Journal:  JAMA Surg       Date:  2014-06       Impact factor: 14.766

3.  Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice.

Authors:  Anthony E Dragun; Bin Huang; Thomas C Tucker; William J Spanos
Journal:  Breast J       Date:  2012-05-21       Impact factor: 2.431

4.  Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2015-07-23       Impact factor: 79.321

5.  Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.

Authors:  Catherine Pesce; Erik Liederbach; Chihsiung Wang; Brittany Lapin; David J Winchester; Katharine Yao
Journal:  Ann Surg Oncol       Date:  2014-08-01       Impact factor: 5.344

6.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.

Authors:  Stewart J Anderson; Irene Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Jong-Hyeon Jeong; Charles E Geyer; D Lawrence Wickerham; Joseph P Costantino; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

7.  Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.

Authors:  Debora de Melo Gagliato; Ana M Gonzalez-Angulo; Xiudong Lei; Richard L Theriault; Sharon H Giordano; Vicente Valero; Gabriel N Hortobagyi; Mariana Chavez-Macgregor
Journal:  J Clin Oncol       Date:  2014-01-27       Impact factor: 44.544

8.  Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy.

Authors:  Katharine Yao; Jeff Belkora; Mark Sisco; Shoshana Rosenberg; Isabelle Bedrosian; Erik Liederbach; Chihsiung Wang
Journal:  JAMA Surg       Date:  2016-04       Impact factor: 14.766

9.  'Taking control of cancer': understanding women's choice for mastectomy.

Authors:  Andrea M Covelli; Nancy N Baxter; Margaret I Fitch; David R McCready; Frances C Wright
Journal:  Ann Surg Oncol       Date:  2014-09-05       Impact factor: 5.344

10.  Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.

Authors:  Biqi Zhang; Suzanne B Coopey; Michele A Gadd; Kevin S Hughes; David C Chang; Tawakalitu O Oseni
Journal:  Ann Surg Oncol       Date:  2019-07-19       Impact factor: 5.344

View more
  3 in total

1.  Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy.

Authors:  Catherine Pesce; Jennifer Jaffe; Kristine Kuchta; Katharine Yao; Mark Sisco
Journal:  Breast Cancer Res Treat       Date:  2020-10-08       Impact factor: 4.872

Review 2.  Addressing the problem of overtreatment in breast cancer.

Authors:  Linda M Pak; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2022-05-19       Impact factor: 3.627

3.  Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients.

Authors:  Jinsun Woo; Geumhee Gwak; Inseok Park; Byung Noe Bae; Se Kyung Lee; Byung Joo Chae; Jonghan Yu; Jeong Eon Lee; Seok Won Kim; Seok Jin Nam; Jai Min Ryu
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.